Pierre Guéret

619 total citations
26 papers, 352 citations indexed

About

Pierre Guéret is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Surgery. According to data from OpenAlex, Pierre Guéret has authored 26 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Hematology and 7 papers in Surgery. Recurrent topics in Pierre Guéret's work include Venous Thromboembolism Diagnosis and Management (7 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Pierre Guéret is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (7 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Pierre Guéret collaborates with scholars based in France, United States and Switzerland. Pierre Guéret's co-authors include Catherine Ternisien, Marc Trossaërt, S. Régina, Marc Fouassier, Yves Gruel, Claire Pouplard, B Astruc, Philippe Legrand, Andreas Krause and Charlotte Baudry and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Physics Today.

In The Last Decade

Pierre Guéret

21 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Guéret France 8 173 130 105 98 82 26 352
Fenny Berends Netherlands 6 104 0.6× 97 0.7× 28 0.3× 80 0.8× 74 0.9× 7 329
Ryan F. Vilardi United States 10 58 0.3× 50 0.4× 190 1.8× 29 0.3× 53 0.6× 11 436
Kelly Henrichs United States 13 70 0.4× 168 1.3× 74 0.7× 11 0.1× 20 0.2× 27 507
G. Aya France 8 77 0.4× 39 0.3× 41 0.4× 18 0.2× 113 1.4× 14 272
Michèle Piot France 9 99 0.6× 129 1.0× 23 0.2× 88 0.9× 127 1.5× 15 280
Abeer Suleiman Israel 8 72 0.4× 31 0.2× 17 0.2× 10 0.1× 215 2.6× 19 463
W. Ehrenthal Germany 11 67 0.4× 74 0.6× 5 0.0× 61 0.6× 131 1.6× 26 304
Charlotte E. van Iperen Netherlands 8 41 0.2× 235 1.8× 17 0.2× 19 0.2× 22 0.3× 9 369
Cynthia Zamora United States 10 154 0.9× 43 0.3× 21 0.2× 22 0.2× 55 0.7× 20 379
Janet V. Johnson United States 7 97 0.6× 44 0.3× 9 0.1× 17 0.2× 347 4.2× 7 502

Countries citing papers authored by Pierre Guéret

Since Specialization
Citations

This map shows the geographic impact of Pierre Guéret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Guéret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Guéret more than expected).

Fields of papers citing papers by Pierre Guéret

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Guéret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Guéret. The network helps show where Pierre Guéret may publish in the future.

Co-authorship network of co-authors of Pierre Guéret

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Guéret. A scholar is included among the top collaborators of Pierre Guéret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Guéret. Pierre Guéret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gouin‐Thibault, Isabelle, Alexandre Mansour, Michaël Hardy, et al.. (2024). Management of Therapeutic-intensity Unfractionated Heparin: A Narrative Review on Critical Points. SHILAP Revista de lepidopterología. 8(3). e297–e307. 4 indexed citations
2.
Gouin‐Thibault, Isabelle, Guillaume Bouzillé, Alice Ballerie, et al.. (2024). Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study. Journal of Thrombosis and Haemostasis. 22(10). 2864–2872.
3.
Guéret, Pierre, et al.. (2023). A performance evaluation of sthemO 301 coagulation analyzer and associated reagents. Journal of Clinical Laboratory Analysis. 37(11-12). e24929–e24929. 4 indexed citations
4.
5.
Guéret, Pierre, et al.. (2021). Management of a High-Risk Surgery with Emicizumab and Factor VIII in a Child with a Severe Hemophilia A and Inhibitor. SHILAP Revista de lepidopterología. 5(2). e163–e165. 2 indexed citations
6.
Ballerie, Alice, Karine Lacut, Hubert Galinat, et al.. (2021). Apixaban and rivaroxaban in obese patients treated for venous thromboembolism: Drug levels and clinical outcomes. Thrombosis Research. 208. 39–44. 15 indexed citations
7.
Drouin, Gaëtan, Daniel Catheline, Pierre Guéret, et al.. (2018). Comparative effects of dietary n-3 docosapentaenoic acid (DPA), DHA and EPA on plasma lipid parameters, oxidative status and fatty acid tissue composition. The Journal of Nutritional Biochemistry. 63. 186–196. 41 indexed citations
8.
Hubert, Arnaud, Pierre Guéret, Guillaume Leurent, et al.. (2017). Myocardial infarction and thrombophilia: Do not miss the right diagnosis!. Revista Portuguesa de Cardiologia. 37(1). 89.e1–89.e4. 3 indexed citations
9.
Guéret, Pierre, S. Combe, Eliane Fuseau, et al.. (2016). Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study. European Journal of Clinical Pharmacology. 73(1). 15–28. 3 indexed citations
10.
Allain, Jean‐Sébastien, Pierre Guéret, Thomas Le Gallou, et al.. (2016). La recherche de thrombophilie héréditaire et son impact thérapeutique dans la maladie thromboembolique veineuse : résultats d’une étude monocentrique rétrospective sur 162 patients. La Revue de Médecine Interne. 37(10). 661–666. 1 indexed citations
11.
Guéret, Pierre, S. Combe, Eliane Fuseau, et al.. (2016). First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action. European Journal of Clinical Pharmacology. 72(9). 1041–1050. 4 indexed citations
12.
Anselmi, Amédéo, P Guinet, Vito Giovanni Ruggieri, et al.. (2015). Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation. European Journal of Cardio-Thoracic Surgery. 49(1). 78–84. 20 indexed citations
13.
Guéret, Pierre, et al.. (2013). EP42675, a synthetic parenteral dual‐action anticoagulant: pharmacokinetics, pharmacodynamics, and absence of interactions with antiplatelet drugs. Journal of Thrombosis and Haemostasis. 12(1). 24–33. 2 indexed citations
14.
Guéret, Pierre & F. Joffre. (2009). Guide de bonnes pratiques et recommandations en imagerie cardiaque en coupes. Archives of Cardiovascular Diseases Supplements. 1(1). 1–1. 2 indexed citations
15.
16.
Pouplard, Claire, Pierre Guéret, Marc Fouassier, et al.. (2007). Prospective evaluation of the ‘4Ts’ score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 5(7). 1373–1379. 131 indexed citations
17.
Héresbach, D., Maël Pagenault, Pierre Guéret, et al.. (1997). Leiden factor V mutation in four patients with small bowel infarctions. Gastroenterology. 113(1). 322–325. 25 indexed citations
18.
Habis, Michel, F Pouillart, Jean‐Pierre Becquemin, & Pierre Guéret. (1996). Ulcère athéromateux pénétrant de l'aorte thoracique. A propos d'un cas.. Archives Des Maladies Du Coeur Et Des Vaisseaux. 89(7). 1 indexed citations
19.
Pohl, Dieter, U. Dürig, & Pierre Guéret. (1995). Resolving Near-Field Microscopy History. Physics Today. 48(1). 74–75. 1 indexed citations
20.
Guéret, Pierre, et al.. (1986). Maladie de Recklinghausen et prolapsus valvulaire mitral. La Presse Médicale. 15(30). 1424–1424. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fenny Berends Breakdown of academic impact, for papers by Ryan F. Vilardi Breakdown of academic impact, for papers by Kelly Henrichs Breakdown of academic impact, for papers by G. Aya Breakdown of academic impact, for papers by Michèle Piot Breakdown of academic impact, for papers by Abeer Suleiman Breakdown of academic impact, for papers by W. Ehrenthal Breakdown of academic impact, for papers by Charlotte E. van Iperen Breakdown of academic impact, for papers by Cynthia Zamora Breakdown of academic impact, for papers by Janet V. Johnson
Rankless by CCL
2026